Cyclo Therapeutics -CW25CYTHWPreferred / convertible
13F holders, Q4 2024 (December 31)3holders +1
1new positions
0sold out
1famous investor
$0.14avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Cyclo Therapeutics -CW25 (CYTHW) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($2K), UBS Group AG ($13) and Bank of America Corp. ($12). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Cyclo Therapeutics -CW25
- CUSIP
- 23254X110
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $13 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 291 shares bought, net +291 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | — | Add +0.9% | 11,693 | $2K |
| UBS Group AG | — | New | 175 | $13 |
| Bank of America Corp. | — | Add +11.1% | 160 | $12 |
"% of holder's portfolio" is CYTHW's weight in each manager's 13F, not the share of Cyclo Therapeutics -CW25 the manager owns.